187 related articles for article (PubMed ID: 32530938)
1. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura F; Fretts A; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Frazier-Wood AC; Del Gobbo LC; Djoussé L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Risérus U; Robinson JG; Samieri C; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JH; Micha R; Forouhi NG; Lemaitre RN; Mozaffarian D;
PLoS Med; 2018 Oct; 15(10):e1002670. PubMed ID: 30303968
[TBL] [Abstract][Full Text] [Related]
3. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
[TBL] [Abstract][Full Text] [Related]
4. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
[TBL] [Abstract][Full Text] [Related]
5. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
[TBL] [Abstract][Full Text] [Related]
6. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
[TBL] [Abstract][Full Text] [Related]
7. A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.
Imamura F; Sharp SJ; Koulman A; Schulze MB; Kröger J; Griffin JL; Huerta JM; Guevara M; Sluijs I; Agudo A; Ardanaz E; Balkau B; Boeing H; Chajes V; Dahm CC; Dow C; Fagherazzi G; Feskens EJM; Franks PW; Gavrila D; Gunter M; Kaaks R; Key TJ; Khaw KT; Kühn T; Melander O; Molina-Portillo E; Nilsson PM; Olsen A; Overvad K; Palli D; Panico S; Rolandsson O; Sieri S; Sacerdote C; Slimani N; Spijkerman AMW; Tjønneland A; Tumino R; van der Schouw YT; Langenberg C; Riboli E; Forouhi NG; Wareham NJ
PLoS Med; 2017 Oct; 14(10):e1002409. PubMed ID: 29020051
[TBL] [Abstract][Full Text] [Related]
8. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
[TBL] [Abstract][Full Text] [Related]
9. Association between erythrocyte fatty acids in de novo lipogenesis pathway and DXA-derived body fat and trunk fat distribution in Chinese adults: a prospective study.
Zeng FF; Chen ZY; Zheng JS; Lin JS; Li YH; Qiu R; Wang C; Sun LL; Chen YM
Eur J Nutr; 2019 Dec; 58(8):3229-3239. PubMed ID: 30470880
[TBL] [Abstract][Full Text] [Related]
10. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
[TBL] [Abstract][Full Text] [Related]
11. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study.
Jacobs S; Jäger S; Jansen E; Peter A; Stefan N; Boeing H; Schulze MB; Kröger J
PLoS One; 2015; 10(5):e0127368. PubMed ID: 25984792
[TBL] [Abstract][Full Text] [Related]
12. Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE).
Lai HTM; Imamura F; Korat AVA; Murphy RA; Tintle N; Bassett JK; Chen J; Kröger J; Chien KL; Senn M; Wood AC; Forouhi NG; Schulze MB; Harris WS; Vasan RS; Hu F; Giles GG; Hodge A; Djousse L; Brouwer IA; Qian F; Sun Q; Wu JHY; Marklund M; Lemaitre RN; Siscovick DS; Fretts AM; Shadyab AH; Manson JE; Howard BV; Robinson JG; Wallace RB; Wareham NJ; Chen YI; Rotter JI; Tsai MY; Micha R; Mozaffarian D;
Diabetes Care; 2022 Apr; 45(4):854-863. PubMed ID: 35142845
[TBL] [Abstract][Full Text] [Related]
13. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
[TBL] [Abstract][Full Text] [Related]
14. Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational studies.
Neuenschwander M; Barbaresko J; Pischke CR; Iser N; Beckhaus J; Schwingshackl L; Schlesinger S
PLoS Med; 2020 Dec; 17(12):e1003347. PubMed ID: 33264277
[TBL] [Abstract][Full Text] [Related]
15. Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort: associations by types, sources of fatty acids and substitution by macronutrients.
Liu S; van der Schouw YT; Soedamah-Muthu SS; Spijkerman AMW; Sluijs I
Eur J Nutr; 2019 Apr; 58(3):1125-1136. PubMed ID: 29524001
[TBL] [Abstract][Full Text] [Related]
16. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
Qian F; Ardisson Korat AV; Imamura F; Marklund M; Tintle N; Virtanen JK; Zhou X; Bassett JK; Lai H; Hirakawa Y; Chien KL; Wood AC; Lankinen M; Murphy RA; Samieri C; Pertiwi K; de Mello VD; Guan W; Forouhi NG; Wareham N; Hu ICFB; Riserus U; Lind L; Harris WS; Shadyab AH; Robinson JG; Steffen LM; Hodge A; Giles GG; Ninomiya T; Uusitupa M; Tuomilehto J; Lindström J; Laakso M; Siscovick DS; Helmer C; Geleijnse JM; Wu JHY; Fretts A; Lemaitre RN; Micha R; Mozaffarian D; Sun Q;
Diabetes Care; 2021 May; 44(5):1133-1142. PubMed ID: 33658295
[TBL] [Abstract][Full Text] [Related]
17. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
[TBL] [Abstract][Full Text] [Related]
18. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies.
Wu JHY; Marklund M; Imamura F; Tintle N; Ardisson Korat AV; de Goede J; Zhou X; Yang WS; de Oliveira Otto MC; Kröger J; Qureshi W; Virtanen JK; Bassett JK; Frazier-Wood AC; Lankinen M; Murphy RA; Rajaobelina K; Del Gobbo LC; Forouhi NG; Luben R; Khaw KT; Wareham N; Kalsbeek A; Veenstra J; Luo J; Hu FB; Lin HJ; Siscovick DS; Boeing H; Chen TA; Steffen B; Steffen LM; Hodge A; Eriksdottir G; Smith AV; Gudnason V; Harris TB; Brouwer IA; Berr C; Helmer C; Samieri C; Laakso M; Tsai MY; Giles GG; Nurmi T; Wagenknecht L; Schulze MB; Lemaitre RN; Chien KL; Soedamah-Muthu SS; Geleijnse JM; Sun Q; Harris WS; Lind L; Ärnlöv J; Riserus U; Micha R; Mozaffarian D;
Lancet Diabetes Endocrinol; 2017 Dec; 5(12):965-974. PubMed ID: 29032079
[TBL] [Abstract][Full Text] [Related]
19. Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies.
Fretts AM; Imamura F; Marklund M; Micha R; Wu JHY; Murphy RA; Chien KL; McKnight B; Tintle N; Forouhi NG; Qureshi WT; Virtanen JK; Wong K; Wood AC; Lankinen M; Rajaobelina K; Harris TB; Djoussé L; Harris B; Wareham NJ; Steffen LM; Laakso M; Veenstra J; Samieri C; Brouwer IA; Yu CI; Koulman A; Steffen BT; Helmer C; Sotoodehnia N; Siscovick D; Gudnason V; ; Wagenknecht L; Voutilainen S; Tsai MY; Uusitupa M; Kalsbeek A; Berr C; Mozaffarian D; Lemaitre RN
Am J Clin Nutr; 2019 Apr; 109(4):1216-1223. PubMed ID: 30982858
[TBL] [Abstract][Full Text] [Related]
20. Circulating Very-Long-Chain SFA Concentrations Are Inversely Associated with Incident Type 2 Diabetes in US Men and Women.
Ardisson Korat AV; Malik VS; Furtado JD; Sacks F; Rosner B; Rexrode KM; Willett WC; Mozaffarian D; Hu FB; Sun Q
J Nutr; 2020 Feb; 150(2):340-349. PubMed ID: 31618417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
